Plasmepsin

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (09:50, 31 August 2023) (edit) (undo)
 
(18 intermediate revisions not shown.)
Line 1: Line 1:
-
{{STRUCTURE_3fns| right| PDB=3fns | SCENE= |CAPTION=Plasmepsin dimer witn Zn+2 ions (grey), [[3fns]] }}
+
<StructureSection load='' size='350' side='right' caption='Plasmepsin II complex with a potential antimalarial drug (PDB entry [[4cku]])' scene='44/441867/Cv/1'>
-
[[Plasmepsin]] (Plm) is a hemoglobin-degrading enzyme produced by the plasmodium parasite. It is a potential target for anti-malaria drugs. It is an aspartic acid protease having 2 aspartic acid residues in the active site. Ten Plm isoforms are known which are named Plm I, II, etc and '''Histo-Aspartic Protease (HAP)'''. '''ProPml II''' exhibits a large shift between its domains which renders the protease inactive.
+
== Function ==
 +
[[Plasmepsin]] (Plm) is a hemoglobin-degrading enzyme produced by the plasmodium parasite. It is an aspartic acid protease having 2 aspartic acid residues in the active site. Ten Plm isoforms are known which are named Plm I, II, etc and '''Histo-Aspartic Protease (HAP)'''.
-
<br />
+
*'''Proplasmepsin II''' exhibits a large shift between its domains which renders the protease inactive<ref>PMID:9886289</ref>.
 +
==Relevance ==
 +
Plm is a potential target for anti-malaria drugs<ref>PMID:25719272</ref>.
 +
 +
== Structural highlights ==
 +
The active site of Plm II contains a <scene name='44/441867/Cv/4'>catalytic dyad of 2 Asp residues which interact with potential antimalarial inhibitor</scene><ref>PMID:24900843</ref>. <scene name='44/441867/Cv/5'>Whole active site</scene>. Water molecules are shown as red spheres.
 +
</StructureSection>
==3D structures of plasmepsin==
==3D structures of plasmepsin==
-
Updated: {{REVISIONDAY2}}-{{REVISIONMONTH}}-{{REVISIONYEAR}} (DD-MM-YYYY)
+
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
 +
{{#tree:id=OrganizedByTopic|openlevels=0|
 +
 
 +
*Histo-Aspartic Protease
 +
 
 +
**[[3fns]], [[3qvc]], [[6kub]], [[6kuc]], [[6kud]] – PfHAP - ''Plasmodium falciparum''<br />
 +
**[[3fnt]] – PfHAP + pepstatin<br />
 +
**[[3fnu]], [[3qvi]] – PfHAP + inhibitor<br />
 +
 
 +
*Plasmepsin I
-
===HAP===
+
**[[3qrv]] – PfPlm I residues 117-457<br />
 +
**[[3qs1]] - PfPlm I residues 117-457 + inhibitor
-
[[3fns]] – PfHAP - ''Plasmodium falciparum''<br />
+
*Plasmepsin II
-
[[3fnt]] – PfHAP + inhibitor pepstatin<br />
+
-
[[3fnu]] – PfHAP + KNI-10006<br />
+
-
===Plm I===
+
**[[1lf4]] – PfPlm II<br />
 +
**[[3f9q]] – PfPlm II (mutant)<br />
 +
**[[2r9b]] – PfPlm II + peptide inhibitor<br />
 +
**[[1w6h]], [[2bju]], [[1lf2]], [[1lf3]], [[1lee]], [[2igx]], [[2igy]], [[4cku]], [[4y6m]], [[4z22]], [[5yia]], [[5yib]], [[5yic]], [[5yid]], [[5yie]], [[7qyh]] – PfPlm II + inhibitor<br />
 +
**[[4ya8]] – PfPlm II (mutant) + inhibitor<br />
 +
**[[7ve0]], [[7ve2]] – PfPlm II + drug<br />
 +
**[[1w6i]], [[1xdh]], [[1xe5]], [[1xe6]], [[1me6]], [[1sme]] – PfPlm II + pepstatin derivative<br />
 +
**[[1m43]] - PfPlm II (mutant) + pepstatin derivative<br />
-
[[3qrv]] – PfPlm I residues 117-457<br />
+
*Plasmepsin IV
-
[[3qs1]] - PfPlm I residues 117-457 + inhibitor
+
-
===Plm II===
+
**[[2anl]] – Plm IV + statine derivative – ''Plasmodium malariae''<br />
 +
**[[1ls5]] - PfPlm IV + pepstatin derivative<br />
-
[[1lf4]] – PfPlm II<br />
+
*Plasmepsin V or aspartic protease PM5
-
[[3f9q]] – PfPlm II (mutant)<br />
+
-
[[2r9b]] – PfPlm II + peptide inhibitor<br />
+
-
[[1w6h]], [[2bju]], [[1lf2]], [[1lf3]], [[1lee]], [[2igx]], [[2igy]] – PfPlm II + inhibitor<br />
+
-
[[1w6i]], [[1xdh]], [[1xe5]], [[1xe6]], [[1me6]], [[1sme]] – PfPlm II + pepstatin derivative<br />
+
-
[[1m43]] - PfPlm II (mutant) + pepstatin derivative<br />
+
-
===ProPlm II===
+
**[[6c4g]] – PvPlm V + inhibitor<br />
 +
**[[4zl4]] – PvPlm V + transition state analog<br />
-
[[1pfz]] - PfProPlm II<br />
+
*Plasmepsin X
-
[[1miq]] – PvProPlm II – ''Plasmodium vivax''<br />
+
-
[[1qs8]] - PvPlm + pepstatin derivative<br />
+
-
===Plm IV===
+
**[[7ry7]] – PvPlm X <br />
 +
**[[7tbc]], [[7tbd]], [[7tbe]], [[8dsr]] – PfPlm X + inhibitor<br />
 +
**[[7tbb]] – PfPlm X <br />
-
[[2anl]] – Plm IV + statine derivative – ''Plasmodium malariae''<br />
+
*Proplasmepsin II
-
[[1ls5]] - PfPlm IV + pepstatin derivative<br />
+
 +
**[[1pfz]], [[5bwy]] - PfProPlm II<br />
 +
**[[1miq]] – PvProPlm II – ''Plasmodium vivax''<br />
 +
**[[1qs8]], [[5i70]] - PvPlm II + pepstatin derivative<br />
 +
}}
 +
== References ==
 +
<references/>
[[Category:Topic Page]]
[[Category:Topic Page]]

Current revision

Plasmepsin II complex with a potential antimalarial drug (PDB entry 4cku)

Drag the structure with the mouse to rotate

3D structures of plasmepsin

Updated on 31-August-2023

References

  1. ↑ Bernstein NK, Cherney MM, Loetscher H, Ridley RG, James MN. Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from plasmodium falciparum. Nat Struct Biol. 1999 Jan;6(1):32-7. PMID:9886289 doi:10.1038/4905
  2. ↑ Huizing AP, Mondal M, Hirsch AK. Fighting malaria: structure-guided discovery of nonpeptidomimetic plasmepsin inhibitors. J Med Chem. 2015 Jul 9;58(13):5151-63. doi: 10.1021/jm5014133. Epub 2015 Mar 17. PMID:25719272 doi:http://dx.doi.org/10.1021/jm5014133
  3. ↑ Jaudzems K, Tars K, Maurops G, Ivdra N, Otikovs M, Leitans J, Kanepe-Lapsa I, Domraceva I, Mutule I, Trapencieris P, Blackman MJ, Jirgensons A. Plasmepsin inhibitory activity and structure-guided optimization of a potent hydroxyethylamine-based antimalarial hit. ACS Med Chem Lett. 2014 Jan 13;5(4):373-7. doi: 10.1021/ml4004952. eCollection, 2014 Apr 10. PMID:24900843 doi:http://dx.doi.org/10.1021/ml4004952

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Joel L. Sussman, Jaime Prilusky

Retrieved from "http://52.214.119.220/wiki/index.php/Plasmepsin"
Personal tools